Aberdeen Group
NSPR icon

Aberdeen Group’s InspireMD NSPR Stock Holding History

Aberdeen Group’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.17M Hold
3,173,364
– – 0.01% 685
2025
Q4 		$5.65M Buy
3,173,364
+692,247
+28% +$1.44M 0.01% 683
2025
Q3 		$5.98M Buy
+2,481,117
New +$6.02M 0.01% 682

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
AF
Affiance Financial St. Louis Park, Minnesota $695M AUM 17.33% 1-Year Est. Return

Aberdeen Group's NSPR Position: Q1 2026 in Review

Aberdeen Group held its InspireMD (NSPR) position steady in Q1 2026 at 3,173,364 shares worth $5.17M. The position accounts for 0.01% of the portfolio, ranked #685.

Aberdeen Group first reported a position in NSPR in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.98M in Q3 2025. 35 funds tracked by Wall St. Rank hold NSPR as of Q1 2026.

  • Aberdeen Group held 3,173,364 shares of InspireMD worth $5.17M as of Q1 2026.
  • Aberdeen Group left its InspireMD share count unchanged in Q1 2026.
  • InspireMD made up 0.01% of Aberdeen Group's portfolio in Q1 2026, its #685 holding.
  • Aberdeen Group first reported a position in InspireMD in Q3 2025 and has held it in 3 quarters since.
  • Aberdeen Group's InspireMD position peaked at $5.98M in Q3 2025.
  • 35 funds tracked by Wall St. Rank held InspireMD as of Q1 2026.

Based on Aberdeen Group's 13F filing for Q1 2026, filed 29 Apr 2026.